Use the "KIDs List" to Identify Risky Meds in Children

August 2020

You'll hear about the new "KIDs List" of Key potentially Inappropriate Drugs in pediatrics...from the Pediatric Pharmacy Assn.

Verify that strategies are in place to evaluate risks of certain meds in kids under 18. Think of these guidelines as "warnings"...similar to how you use the Beers Criteria in the elderly.

Antiemetics. Be cautious with all forms of dopamine blockers (prochlorperazine, promethazine, etc) in kids...and avoid in those under age 2...due to respiratory depression or dyskinesia.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Infectious Diseases Consider Steroids for Some Hospitalized COVID-19 Patients
Venous Thromboembolism Weigh VTE Prevention Strategies in COVID-19
Influenza Optimize Flu Vaccinations for 2020-21
Antimicrobial Stewardship Focus on Antimicrobial Stewardship During Care Transitions
Emergency Medicine Advise on Safe Med Use for Rapid Sequence Intubation
Pediatrics Use the "KIDs List" to Identify Risky Meds in Children
Insulin Compare Lyumjev and Semglee to Other Insulins
Wound Care Identify Who Needs Tetanus Vaccine and Immune Globulin
Gastroenterology Address Med Concerns for Patients With Dysphagia

Use the "KIDs List" to Identify Risky Meds in Children

Get unlimited access through an Enterprise license

Table of Contents